Caren van Roekel

282 Chapter 10 34. Network NCC. Clinical practice guidelines in oncology: colon cancer. National Comprehensive Cancer Network; 2016 [cited 2020 March 12]; Available from: https://www.nccn.org/professionals/ physician_gls/PDF/colon.pdf. 35. Wasan HS, Gibbs P, Sharma NK, Taieb J, Heinemann V, Ricke J, et al. First-line selective internal radiotherapy plus chemotherapy versus chemotherapy alone in patients with liver metastases from colorectal cancer (FOXFIRE, SIRFLOX, and FOXFIRE-Global): a combined analysis of three multicentre, randomised, phase 3 trials. Lancet Oncol. 2017. 36. Lam MG, Louie JD, Abdelmaksoud MH, Fisher GA, Cho-Phan CD, Sze DY. Limitations of body surface area-based activity calculation for radioembolization of hepatic metastases in colorectal cancer. J Vasc Interv Radiol. 2014;25(7):1085-93. Epub 2014/01/25. 37. Tohme S, Sukato D, Nace GW, Zajko A, Amesur N, Orons P, et al. Survival and tolerability of liver radioembolization: a comparison of elderly and younger patients with metastatic colorectal cancer. HPB. 2014;16(12):1110-6. Epub 2014/08/16. 38. Soydal C, Kucuk NO, Balci D, Gecim E, Bilgic S, Elhan AH. Prognostic Importance of the Presence of Early Metabolic Response and Absence of Extrahepatic Metastasis After Selective Internal Radiation Therapy in Colorectal Cancer Liver Metastasis. Cancer Biother Radiopharm. 2016;31(9):342-6. Epub 2016/11/11. 39. Cassidy J, Twelves C, Van Cutsem E, Hoff P, Bajetta E, Boyer M, et al. First-line oral capecitabine therapy in metastatic colorectal cancer: a favorable safety profile compared with intravenous 5-fluorouracil/leucovorin. Ann Oncol. 2002;13(4):566-75. Epub 2002/06/12. 40. Cunningham D, Lang I, Marcuello E, Lorusso V, Ocvirk J, Shin DB, et al. Bevacizumab plus capecitabine versus capecitabine alone in elderly patients with previously untreated metastatic colorectal cancer (AVEX): an open-label, randomised phase 3 trial. Lancet Oncol. 2013;14(11):1077-85. 41. Kennedy AS, Ball DS, Cohen SJ, Cohn M, Coldwell D, Drooz A, et al. Safety and Efficacy of Radioembolization in Elderly (>/= 70 Years) and Younger Patients With Unresectable Liver-Dominant Colorectal Cancer. Clin Colorect Cancer. 2016;15(2):141-51 e6. Epub 2015/11/07. 42. Seidensticker R, Damm R, Enge J, Seidensticker M, Mohnike K, Pech M, et al. Local ablation or radioembolization of colorectal cancer metastases: comorbidities or older age do not affect overall survival. BMC Cancer. 2018;18(1):882. Epub 2018/09/12. 43. Hickey R, Lewandowski RJ, Prudhomme T, Ehrenwald E, Baigorri B, Critchfield J, et al. 90Y Radioembolization of Colorectal Hepatic Metastases Using Glass Microspheres: Safety and Survival Outcomes from a 531-Patient Multicenter Study. J Nucl Med. 2016;57(5):665-71. Epub 2015/12/05.